« Cephalon's Latest Buy is ChemGenex | Main | Lonza invests in biomanufacturing »

03/29/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e870d3039970d

Listed below are links to weblogs that reference NIH hasn't Forgotten Neuroscience Drugs:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

arash sabour

i am currently taking a drug that has some neuroprotective qualities but has other bad side effects and detriments. The quest in neuroscience, I believe is to produce therapies that can address a broad range of diseases and potentially treat a larger segment of population suffering from undiagnosed, unsolicitated deficiences in neuroprotective arena. The theory is that society as a whole can benefit from treatments that are holistic and that benefit humanity in quality of life and productivity. Why are they only treating the diseases that make headlines, i see alot of people suffering who don't dare speak up and take low quality of life, as something to be endured. Neuroscience can change the landscape and the human mindset that is excessively redundant and harmful.
Imagine therapies that help the world gain better life standards, change their behaviour and outlook. Neuroprotectorants are good for brain and cardiovascular health prevention and to enhance human qualities beneficial to world peace and productivity.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada